05/01/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/1/2020. This statement summarizes the third meeting of the Emergency Committee convened by the World Health Organization (WHO) Director-General under the International Health Regulations (2005) (IHR) regarding the coronavirus disease (COVID-19), which took place on Thursday, April 30, 2020. It lists advice given to the WHO for coordination, planning, and monitoring; One Health; essential health services; risk communication and community engagement; surveillance; and travel and trade. It also lists advice given to all State Parties, including for additional health measures and health workers. (Text)
05/01/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/1/2020. The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product remdesivir for treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalized with severe disease. This 36-page fact sheet provides essential information on the use of remdesivir, an unapproved drug, to treat suspected or laboratory confirmed COVID-19. (PDF)
05/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/1/2020. This web page provides interim guidance to reduce the risk of introducing and transmitting SARS-CoV-2 (the virus responsible for causing COVID-19) in cleaner air shelters and cleaner air spaces that are public spaces where people can seek relief from wildfire smoke. This interim guidance is intended for use by federal, state, local, and tribal jurisdictions in the United States. It should be used in conjunction with existing cleaner air shelter information, procedures, guidance, and resources. (Text)
05/01/2020 12:00 AM EDT
Source: Imperial College London. Published: 5/1/2020. This 29-page report aims to quantify the extent to which disruptions caused by the COVID-19 pandemic in services for HIV, TB, and malaria in high burden low- and middle-income countries could lead to additional loss of life. In high burden settings, HIV, TB, and malaria related deaths over five years may be increased by up to 10 percent, 20 percent, and 36 percent, respectively, compared to if there were no COVID-19 epidemic. (PDF)
05/01/2020 12:00 AM EDT
Source: Association of State and Territorial Health Officials (ASTHO). Published: 5/2020. As the nation looks to restart the economy and recover from the COVID-19 pandemic, this 13-page document describes how reopening entirely will depend on expanded public health testing and contact tracing efforts, sustained healthcare system capacity to respond to new outbreaks, and public compliance with existing and new containment and mitigation efforts. (PDF)
04/30/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/30/2020. This guidance is intended to assist nursing homes and public health authorities with response and cohorting decisions for COVID-19 in nursing homes. Guidance is provided for Resident Cohorting; Response to Newly Identified SARS-CoV-2-infected Healthcare Providers or Residents; and Use of Testing to Inform the Response to COVID-19 in Nursing Homes. (Text)
04/30/2020 12:00 AM EDT
Source: Occupational Safety and Health Administration [U.S. Department of Labor] (OSHA). Published: 4/30/2020. This guidance for dentistry workers and employers supplements the general interim guidance for workers and employers of workers at increased risk of occupational exposure to SARS-CoV-2, the virus that causes COVID-19. A table details dentistry work tasks associated with exposure risk levels. (Text)
04/29/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 4/29/2020. In response to the COVID-19 outbreak, the Centers for Medicare and Medicaid Services (CMS) is empowered to take proactive steps through 1135 waivers and rapidly expand efforts against COVID-19. This 36-page document, updated on April 29, 2020, describes the blanket waivers that are in effect. (PDF)
04/28/2020 12:00 AM EDT
Source: Henry J. Kaiser Family Foundation. Published: 4/28/2020. This analysis examines variation across states in providing regulatory guidance for nursing facilities and assisted living facilities during the COVID-19 pandemic for the three key measures identified by the Centers for Medicare & Medicaid Services: prohibiting visitors to facilities except for end-of-life situations, performing daily staff screening for illness, and universal use of personal protective equipment by facility staff. (Text)
04/24/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/24/2020. This web page, updated on April 24, 2020, provides information and resources about COVID-19 for state, local, territorial, and tribal health departments. Information topics are Evaluating PUIs Residential; Travel-Associated Exposures: Public health recommendations; Pandemic Preparedness: Preparing for a pandemic; Reporting a Confirmed Case: Reporting and specimen referral; Community-Related Exposures: Public health recommendations; and Keeping America Open: Resources to get and keep America open. (Text)
04/23/2020 12:00 AM EDT
Source: World Bank. Published: 4/23/2020. This 62-page paper provides novel evidence from a survey of public health workers in Bihar, India’s poorest state, that supports the insights of economic theory and taken together, yields ideas that can immediately be put to work in policy responses to the COVID-19 crisis. These ideas address problems of governance and trust that have bedeviled health policymakers. (PDF)
04/20/2020 12:00 AM EDT
Source: Council on Foreign Relations. Published: 4/20/2020. This resource, updated on April 20, 2020, provides background information about the Ebola virus, where it has occurred, and how it is contained. It discusses how response partners have continued to struggle to control the disease, despite the use of an experimental vaccine, as a new outbreak in the Democratic Republic of the Congo in 2018 grew to become the second largest ever. (Text)
04/01/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Africa. Published: 4/2020. This 20-page document offers guidance to Member States in the African region on the key steps used to conduct contact tracing related to the COVID-19 response. It is to be used by national and local health authorities in the implementation of tracing of contacts of probable and confirmed COVID-19 cases. (PDF)
04/01/2020 12:00 AM EDT
Source: American Hospital Association (AHA). Published: 4/2020. This seven-page, three-step guide for hospitals and health systems provides strategic considerations to form partnerships during the COVID-19 pandemic. In less than an hour, think through what you should be collaborating on, who your partners should be, and how you can work together to combat COVID-19. (PDF)
11/11/2019 12:00 AM EST
Source: World Health Organization (WHO). Published: 11/11/2019. This 102-page document provides guidance to national regulatory authorities and vaccine manufacturers on the manufacturing processes and nonclinical and clinical evaluation of human respiratory syncytial virus (RSV) vaccines required to assure their quality, safety, and efficacy. The scope of the document encompasses the leading technologies currently being used to develop prophylactic RSV vaccines at the clinical development stage. (PDF)
.png)
No hay comentarios:
Publicar un comentario